Strategically Comprehensive Immunotherapy Employing Modified Antibody Targeting NY-ESO-1 for Multiple Myeloma

被引：0
|
作者：
Maruta, Masaki [1 ]
Tanimoto, Kazushi [1 ]
Azuma, Taichi [1 ]
Fujiwara, Hiroshi [1 ]
Yasukawa, Masaki [1 ]
机构：
[1] Ehime Univ, Sch Med, Dept Int Med 1, Matsuyama, Ehime, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Immune cell therapy; Multiple myeloma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2374
引用
收藏
页码：757 / 757
页数：1
相关论文
共 50 条
  • [41] HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer
    Sonpavde, Guru
    Wang, Mingjun
    Peterson, Leif E.
    Wang, Helen Y.
    Joe, Teresa
    Mims, Martha P.
    Kadmon, Dov
    Ittmann, Michael M.
    Wheeler, Thomas M.
    Gee, Adrian P.
    Wang, Rong-Fu
    Hayes, Teresa G.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 235 - 242
  • [42] Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
    Afsheen Raza
    Maysaloun Merhi
    Varghese Philipose Inchakalody
    Roopesh Krishnankutty
    Allan Relecom
    Shahab Uddin
    Said Dermime
    Journal of Translational Medicine, 18
  • [43] Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation
    Tim Luetkens
    Sebastian Kobold
    Yanran Cao
    Marina Ristic
    Georgia Schilling
    Sinje Tams
    Britta Marlen Bartels
    Julia Templin
    Katrin Bartels
    York Hildebrandt
    Sara Yousef
    Andreas Marx
    Friedrich Haag
    Carsten Bokemeyer
    Nicolaus Kröger
    Djordje Atanackovic
    Cancer Immunology, Immunotherapy, 2014, 63 : 1151 - 1162
  • [44] NOVEL HYPOMETHYLATING AGENT GSK-3484862 SENSITIZES GLIOBLASTOMA TO NY-ESO-1 SPECIFIC IMMUNOTHERAPY
    Li, Kevin
    Lai, Thomas
    Prins, Robert
    Everson, Richard
    NEURO-ONCOLOGY, 2023, 25
  • [45] Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
    Raza, Afsheen
    Merhi, Maysaloun
    Inchakalody, Varghese Philipose
    Krishnankutty, Roopesh
    Relecom, Allan
    Uddin, Shahab
    Dermime, Said
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [46] HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer
    Guru Sonpavde
    Mingjun Wang
    Leif E. Peterson
    Helen Y. Wang
    Teresa Joe
    Martha P. Mims
    Dov Kadmon
    Michael M. Ittmann
    Thomas M. Wheeler
    Adrian P. Gee
    Rong-Fu Wang
    Teresa G. Hayes
    Investigational New Drugs, 2014, 32 : 235 - 242
  • [47] Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma
    Batchu, RB
    Moreno, AM
    Szmania, SM
    Bennett, G
    Spagnoli, GC
    Ponnazhagan, S
    Barlogie, B
    Tricot, G
    van Rhee, F
    CANCER RESEARCH, 2005, 65 (21) : 10041 - 10049
  • [48] Intra- and intertumoral variation in the expression of Cancer Testis antigens, MAGE-3 and NY-ESO-1 in multiple myeloma.
    Gupta, SK
    Lin, P
    Droogenbroeck, J
    Szmania, S
    Yacobby, S
    Batchu, R
    Spagnoli, G
    Tricot, G
    Epstein, J
    van Rhee, F
    BLOOD, 2002, 100 (11) : 603A - 603A
  • [49] Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432
    Aoki, Masatoshi
    Ueda, Shugo
    Nishikawa, Hiroyoshi
    Kitano, Shigehisa
    Hirayama, Michiko
    Ikeda, Hiroaki
    Toyoda, Hideki
    Tanaka, Kyosuke
    Kanai, Michiyuki
    Takabayashi, Arimichi
    Imai, Hiroshi
    Shiraishi, Taizo
    Sato, Eiichi
    Wada, Hisashi
    Nakayama, Eiichi
    Takei, Yoshiyuki
    Katayama, Naoyuki
    Shiku, Hiroshi
    Kageyama, Shinichi
    VACCINE, 2009, 27 (49) : 6854 - 6861
  • [50] Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation
    Luetkens, Tim
    Kobold, Sebastian
    Cao, Yanran
    Ristic, Marina
    Schilling, Georgia
    Tams, Sinje
    Bartels, Britta Marlen
    Templin, Julia
    Bartels, Katrin
    Hildebrandt, York
    Yousef, Sara
    Marx, Andreas
    Haag, Friedrich
    Bokemeyer, Carsten
    Kroeger, Nicolaus
    Atanackovic, Djordje
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (11) : 1151 - 1162
12345